Japer Therapeutics Warrants
JSPRW
7 hedge funds and large institutions have $372K invested in Japer Therapeutics Warrants in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 4 closing their positions.
22% less funds holding
Funds holding: 9 → 7 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
51% less capital invested
Capital invested by funds: $761K → $372K (-$390K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$911 |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$34 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
-$1.03K |
| 2 |
TC
T3 Companies
New York
|
-$569 |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$4 |
| 4 |
CS
Clear Street
New York
|
-$4 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $313K | – | – | – |
|
|
2
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $47.8K | -$1.03K | -31,828 | -1% |
|
|
TCM
3
Tenor Capital Management
New York
| $5.47K | – | – | – |
|
4
Walleye Capital
New York
| $4.38K | – | – | – |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $618 | +$911 | +28,200 | New |
|
6
JP Morgan Chase
New York
| $59 | – | – | – |
|
|
WAM
7
Wolverine Asset Management
Chicago,
Illinois
| $23 | +$34 | +1,039 | New |
|
|
IA
8
IFP Advisors
Tampa,
Florida
| $1 | – | – | – |
|
|
TC
9
T3 Companies
New York
| – | -$569 | -14,200 | Closed |
|
|
10
Bank of America
Charlotte,
North Carolina
| – | -$4 | -100 | Closed |
|
|
CS
11
Clear Street
New York
| – | -$4 | -100 | Closed |
|
JSPRW Hedge Fund Activity: Q1 2026 in Review
7 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Japer Therapeutics Warrants (JSPRW) for Q1 2026, worth a combined $372K — down 51% from $761K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of JSPRW and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 0 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $911. The largest seller was Toronto Dominion Bank, cutting an estimated $1.03K.
- 7 institutional investors held Japer Therapeutics Warrants (JSPRW) as of Q1 2026, down from 9 in Q4 2025.
- Funds reported $372K of Japer Therapeutics Warrants stock for Q1 2026, down 51% quarter-over-quarter.
- 2 funds opened new Japer Therapeutics Warrants positions in Q1 2026 and 4 closed out, a net change of -2 holders.
- The largest Japer Therapeutics Warrants buyer in Q1 2026 was Susquehanna International Group, an estimated $911 added.
- The largest Japer Therapeutics Warrants seller in Q1 2026 was Toronto Dominion Bank, an estimated $1.03K sold.
Based on aggregated 13F filings for Q1 2026.